TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Travasol 4.25% Sulfite Free W/ Electrolytes In Dextrose 15% In Plastic Container patents expire, and what generic alternatives are available?
Travasol 4.25% Sulfite Free W/ Electrolytes In Dextrose 15% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER is amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride. There is one drug master file entry for this compound. Additional details are available on the amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER?
- What are the global sales for TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER?
Summary for TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER at DailyMed |
US Patents and Regulatory Information for TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 15% IN PLASTIC CONTAINER | amino acids; dextrose; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride | INJECTABLE;INJECTION | 020147-008 | Oct 23, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
